Work

Performance-based managed entry agreements for new medicines in OECD countries and EU member states

Year: 2019

Type: report

Abstract: This paper presents findings of an OECD review of managed entry agreements in OECD countries and EU member states conducted in 2018 and 2019. Findings are based on discussions with the OECD Expert Group on Pharmaceuticals and Medical Devices, responses by experts from 12 OECD countries to a survey and semi-structured interviews, and on the literature as well as information published by national authorities responsible for coverage and pricing of medicines.

Source: OECD health working papers

DOI: 10.1787/6e5e4c0f-en

Authors: Martin Wenzl, Suzannah Chapman

Institution: Organisation de Coopération et de Développement Economiques

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: hybrid

Funders: European Commission, University of Edinburgh, Third Health Programme